Ayurvedic Unani Drug – The sale or facilitation of the sale of such specific drugs will take place only after a valid prescription from a registered physician is uploaded to the platform. The CCPA said that necessary action can be taken under the provisions of the Consumer Protection Act of 2019 if the legal framework is violated. The consumer watchdog said taking such drugs without medical supervision could lead to serious health complications.
Ayurvedic Unani Drug
The Central Consumer Protection Authority CCPA on Thursday July 14 issued a notice to e commerce platform directing them to ensure that the sale of certain Ayurvedic, siddha and unani medicines is only made with a valid prescription.
Read Also : Detect Technologies Bags $28 Mn Series B Funding
The CCPA has issued a notice to e-commerce entities regarding the sale of Ayurvedic, siddha, and unani drugs that contain ingredients listed in Schedule E1 of the Drug and Cosmetic Rules of 1945, the notice said.
The CCPA further said E-commerce platforms have been advised that the sale or facilitation of the sale of such medicines will take place only after the user upload to the platform a valid prescription from a registered practitioner of Ayurveda, Siddha or Unani, respectively.
The consumer watchdog said taking such drugs without medical supervision could lead to serious health complications. (Unani Drug)
Schedule E1 of the Drugs and Cosmetics Rules 1945 refers to the list of poisonous substances under the Ayurvedic, Siddha, and Unani systems of medicine and includes items such as cannabis sativa, snake venom, arsenic, among others.
The Central Authority may initiate necessary actions under the provisions of the Consumer Protection Act 2019 if, after investigation, it is determined that such medicines are offered for sale by any e commerce platform in violation of the framework law that govern the sale of said medications to be consumed, said the notice. (Unani Drug)
Reiterating the rules, the notice also specified that the container containing such substances must be labeled with the words Caution: To be taken under medical supervision in English and Hindi.
The Ministry of AYUSH issued a similar public notice in 2016, urging the public to avoid taking such drugs without medical supervision.
Lately, the CCPA has lashed out at misguided players. Earlier this month, the watchdog issued guidelines on charging service charges at hotels and restaurants. Before that, it also issued guidelines for the prevention of misleading advertisements to protect the interests of consumers. (Unani Drug)
Earlier last month, the CCPA also sent notices to ride hailing apps Uber and Ola about growing complaints of consumer rights violations and unfair business practices.